Written Question·Department of Health and Social Care·UIN 68010

Gabapentin

Tabled: 15 July 2025

Answered: 22 July 2025

Question

Carla Lockhart

To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the potential link between the use of gabapentin and cognitive impairment in patients.

Answer

Karin Smyth

The Medicines and Healthcare Products Regulatory Agency (MHRA) is an executive agency of the Department and regulates medicine, medical devices, and blood components for transfusion in the United Kingdom, with responsibility for ensuring medicines meet ap...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 68010) →